Evidence map›Paper›PMID 41988401›Full record

ArticleFrontiers in artificial intelligence2026

A multi-layer annotated corpus for information extraction in Russian clinical NLP.

Anar Sultangaziyeva, Madina Sambetbayeva, Nurzhan Mukazhanov, Bayangali Abdygalym, Sandugash Serikbayeva

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anar SultangaziyevaDepartment of Science and Cooperation, Q University, Almaty, Kazakhstan.
Madina SambetbayevaDepartment of Science and Cooperation, Q University, Almaty, Kazakhstan.
Nurzhan MukazhanovDepartment of Science and Cooperation, Q University, Almaty, Kazakhstan.
Bayangali AbdygalymDepartment of Science and Cooperation, Q University, Almaty, Kazakhstan.
Sandugash SerikbayevaDepartment of Science and Cooperation, Q University, Almaty, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Clinical exome sequencing reports contain valuable genetic and phenotypic information but are typically stored in unstructured text form, making automated biomedical information extraction challenging. For the Russian language, publicly available annotated corpora for genetic report analysis remain extremely limited. Methods: We present GENEXOM, the first multi-level annotated corpus of Russian-language clinical exome sequencing reports designed for biomedical information extraction. The corpus includes 5,318 reports (318 authentic and 5,000 synthetic) and comprises 16 entity types and 7 relation types aligned with HGVS, OMIM, ClinVar, and ACMG/AMP standards. Annotation was performed in the Label Studio platform by expert geneticists. Baseline transformer models (RuBERT, RuBioBERT, ModernBERT) were fine-tuned for Named Entity Recognition (NER) and Relation Extraction (RE). Results: The annotation achieved span-level F1-IAA = 0.83 and macro Discussion: The GENEXOM corpus provides a linguistically and clinically adapted resource for Russian medical NLP and supports downstream tasks such as variant interpretation, phenotype-disease mapping, and biomedical knowledge graph construction. The corpus and accompanying code are publicly available for research purposes.

Indexed as

biomedical natural language processing (BioNLP)genetic diagnosticsGENEXOM corpusinformation extractionnamed entity recognition (NER)relation extraction (RE)Russian clinical reportstransformer-based models

Identifiers

PMID41988401
PMCPMC13077974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.